Alumni workshop 2017

Alumni Workshop: Beyond capacity building November 15 & 16, 2017, Lyon

The University of Lyon hosted the Institute for Global Health (IFGH) University of Siena- First Alumni Workshop (“Beyond Capacity Building”) of the Master in Vaccinology and Pharmaceutical Clinical Development. The event was held on November 15 and 16, 2017 at the Université De Lyon, France.
Sponsors, worldwide vaccines experts and more importantly, THEM: THE ALUMNI, of the unique Master in Vaccinology were present at the event.

The meeting was opened by the Alumni and followed by the University of Siena, President Prof Francesco Frati, and the Program Directors Prof. Sue Ann Costa Clemens and Prof. Emanuele Montomoli .
Dr. Bernadette Hendrickx, program faculty and master of ceremony had the great honor to introduce Dr. Alain Mérieux and the faculty of the program, amongst other important guests: Prof. Pierre Van Dame ( Univ. Antwerp), Dr. Ralf Clemens (BMGF, IVI), Baron Jean Stephenne, Dr. Nathalie Garcon (BioAster), Dr. Lutz Hegeman (Novartis), Dr. John Weil (Takeda Vaccines), Dr. Age Noerdal (CEPI), Drs. Thy Pham and Thandi Onami (Bill and Melinda Gates Foundation), Dr. Marie Jose Quentin (Sanofi Pasteur) and upper management of the University of Lyon, Prof. Martinot, as well as other participants from Paxvax, MedCago, Valneva, Curevac, IAK, Vaxtrials, Fidec, FCD.

“It is a matter of great pride to see the Masters in Vaccinology projects reaching such astounding heights and success. It only speaks of the vision and continuous hard work by the management, academic staff and sponsors. Please accept my heartfelt facilitations and congratulations on this achievement.”
Dr. Ahmad Arslam (Master 2nd edition)- speaker at the event opening

“I think all of my success now coming from the benefit of Master. This course take me go deeply in vaccinology and become a well known on vaccine, EPI and vaccine trial in Vietnam. I am so proud to say that “I was a Master student in Sienna”
Dr. Trong Toan (Master 2nd Edition) speaker at the event

“This is a great achievement for me and I would like to thank you once again for all your support and more than that for giving me the change of being part of something unique, the Masters in Vaccinology.”
Dr. Alex Bica (Master 4th edition ) about thesis to be published by the European Journal of Public Health. The manuscript is entitled “Vaccination policies of immigrants in the EU/EEA Member States – the measles immunisation example”

Launch of the Institute for Global Health at the University of Siena

The Institute for Global Health is born at the University of Siena
A major international project dedicated to public health

This strategic initiative aims to combine leading expertise with cutting-edge innovation capabilities for superior training in the development of vaccines and drugs against infectious diseases

(Siena) The inauguration of the Institute for Global Health (IFGH), an international project of the University of Siena, was held this morning at the Santa Chiara Lab. The initiative is dedicated to the issues of public health and the development of vaccines and drugs for the control and prevention of infectious diseases. The Institute’s goal is to be a center of excellence dedicated to high education, through capacity building and technology transfer processes, involving the best global researchers, faculty, and pharmaceutical managers.
The IFGH has already started this process by developing partnerships with international research institutions, universities, nonprofit organizations and industries. Among them, in particular, stands the collaboration with the Bill & Melinda Gates Foundation, whose chairman Trevor Mundel – a faculty member – participated in the public presentation of the project.
As the University Rector, Prof. Francesco Frati, pointed out: “the Institute for Global Health is the natural evolution of the solid tradition that public health research has achieved at the University of Siena. Its purpose is to concentrate the best initiatives and high-level training programs, defining a unique strategy that will bring international synergies and attract targeted investments. Thanks to our scientific and educational capabilities, we are able to offer students all over the world training opportunities to stimulate innovative research and develop competencies in the fields of vaccinology and public health. ”
As part of the new initiative, the Master Program in Public Health, Pharmaceutical Biotechnology and Clinical Development was created in collaboration with the Incheon National University of South Korea and its Rector, Professor Dong-Sung Cho. The Master Program is the result of a two-year agreement signed in South Korea by the two universities. Classes will start in the coming months and will take place at the two universities.
The Institute for Global Health, based in the Santa Chiara Lab, will be chaired by Professor Emanuele Montomoli and directed by Professor Sue Ann Costa Clemens. Upcoming PhD programs will be coordinated by Professor Pietro Lupetti, Rector’s Deputy.
In addition to Masters and Doctoral programs, IFGH’s activities will include specialized training and continued education programs for vaccinology and pharmaceutical professionals. These programs will also be carried out abroad, with a particular focus on the deepening issues of public health within developing countries.

University of Siena press release http://www.comunicatistampa.unisi.it/dett_comunicato.php?idcs=6917

 

Agreement between UniSi and INU

  • Siena – The University of Siena establishes relationship enhancement in Asia

The President Frati signs an agreement in South Korea for a Master in Healthcare

After the agreements in China, the University of Siena follows its path of internalization to Asia. The Rector Francesco Frati signed in South Korea an agreement with the Incheon National University, aiming to have a Master Executive in “Public Health, Pharmaceutical Biotechnology and Clinical Development”, which allows a further extension in Asia of the already set Master in Vaccinology.
The Master’s official communication will come out in the coming weeks, and it will be performed in Siena, at the Santa Chiara Lab, in one of the strategical projects of its structure: the Institute for Global Health. Parts of the training activities will be performed at the Incheon National University.
The course will be open to bachelor degree candidates in biology, life sciences, medicine, medical related areas, degrees in public health, biotechnology and development, coming from South Korea and all countries in the World.
The studies of Incheon University are relevant in the fields of public health and biomedicine for the specific training that will be offered in the master. Moreover, many biotech and pharma industries of South Korea and other international will support the initiative.
Ufficio Stampa
uffstampa@unisi.it
Tel.: 0577 235331 -32 -33
Source: